Get In Touch

Calcium Channel Blocker Market - Overview

A medication that squares the passage of calcium into the muscle cells of the heart and the supply routes. It is the section of calcium into cells that makes the heart agreement and veins to limit.  A medication that squares the section of calcium into the muscle cells of the heart and the courses is called calcium channel blocker. Calcium channel blockers (CCBs), which are likewise called calcium channel enemies, or calcium opponents, are most generally utilized as antihypertensive medications. Prescription containing calcium channel blockers are utilized for controlling the circulatory strain in patients who are experiencing hypertension. They help decrease the measure of calcium that goes into the heart muscle cells and cause them to unwind.

A medicine that squares the segment of calcium into muscle cells of the heart and the courses is called calcium channel blocker. It is the part of calcium into the cells that settles on the heart understanding and supply courses to restrict. Remedy containing calcium channel blockers are utilized to control the circulatory strain in patients who are encountering hypertension. Calcium channel blockers are overwhelmingly used to change the beat, to decrease chest torture, and to prevent cerebral vasospasm. Such blockers are significantly effective when diverged from beta blockers in cutting down the peril of cardiovascular mortality.

Calcium channel blockers (CCBs), which are also called calcium channel antagonists, or calcium antagonists, are most commonly used as antihypertensive drugs. Medication containing calcium channel blockers are utilized to control the blood pressure in patients who are suffering from hypertension. CCBs are predominantly used to alter the heart rate, to reduce chest pain, and to prevent cerebral vasospasm. CCBs are highly effective as compared to beta blockers in lowering the risk of cardiovascular mortality. They help reduce the amount of calcium that goes into the cardiac muscle cells and cause them to relax. Changing lifestyle of people across all regions led to an increase in the number of stress related disease, which is a major factor, which in turn is anticipated to drive the calcium channel blocker market. However, side effects related to calcium channel blockers such as edema, headache, rapid heart rate, and constipation are likely to hamper the overall demand for calcium channel blocker market.

Calcium Channel Blocker Market: Segmentation:

Based on drug type, the calcium channel blocker market is segmented into dihydropyridine and non-dihydropyridine. Dihydropyridine is anticipated to hold a major share of the market and is likely to expand at a significant growth rate during the forecast period. Expansion of the pharmaceutical industry coupled with an increase in R&D activities related to cardiovascular diseases and easy availability of drugs at low cost are major factors that are anticipated to drive the demand for calcium channel blockers in the dihydropyridine segment.

Dihydropyridine is popularly known as calcium channel brokers. In pharmacology, dihydropyridine is called L-Type channel brokers. Dihydropyridine is utilized in the treatment of hypertension. Dihydropyridines have high vascular selectivity due to which, these drugs are primarily employed to control the arterial pressure and vascular resistance. This is the primary reason, dihydropyridine is used for hypertension treatment. Dihydropyridines includes various drugs such as felodipine, amlodipine, nimodipine, nitrendipine etc. The dihydropyridine drugs are very easy to identify as its drug names end with ‘pine’. However, non-dihydropyridine results into more cardiac depression than dihydropyridine calcium channel blocker. Verapamil and diltiazem are two major drugs that belong to non-dihydropyridine CCBs, which are used clinically.

Based on treatment, the calcium channel blocker market can be segregated into hypertension, pregnancy, anti-obesity, angina pectoris, and others. The hypertension treatment segment is expected to dominate the market during the forecast period and is anticipated to expand at a significant growth rate during forecast period. Verapamil and amlodipine are majorly utilized in the pharmaceutical industry for hypertension and obesity treatment.

Calcium Channel Blocker Market: Region-wise Outlook:

Based on region, the calcium channel blocker market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of consumption, North America held a major share of the calcium channel blocker market. Rise in the geriatric population and concern over diseases related to obesity are the major factors which are anticipated to drive the demand for calcium channel blockers during the forecast period. In terms of consumption, Asia Pacific is anticipated to expand at a significant growth rate during the forecast period. Change in lifestyle and the increase in obesity among the young population in Asia Pacific leads to hypertension and anxiety disorders. These are the major factors which are estimated to drive the demand for calcium channel blockers during the forecast period.

Calcium Channel Blocker Market: Key Players:

Leading pharmaceutical manufacturers across the globe are majorly producing calcium channel blockers across major regions. Some prominent manufacturers of calcium channel blockers are ClearSynth, GlaxoSmithKline Plc., Pfizer Inc., AbMole Bioscience, Lupin Pharmaceuticals, Inc. 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Calcium Channel Blockers Market

Pre Book